Govwatch

Introduced

In Committee

3

Passed One Chamber

4

Passed Both

5

Signed into Law

Sponsor

Diana DeGette

Democrat · CO · Representative

Votes with party: 98.4% (548 recorded votes)

Full profile: /officials/D000197

Source: Congress.gov · FEC

Cosponsors (41)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Referred to the House Committee on Energy and Commerce.

2026-01-21

Source: Congress.gov

Committee Activity

Currently in

House Committee on Energy and CommerceReferred To · 2026-01-21

Previously

Energy and Commerce CommitteeReferred To · 2026-01-21

Plain-English Summary

The bill aims to strengthen how federal health agencies use scientific evidence when making decisions about public health policies and regulations. It likely requires agencies like the FDA and CDC to base their rules on the best available research and to be transparent about the scientific reasoning behind their choices. This would affect how quickly new medicines are approved, what health warnings appear on products, and what guidance the government gives to doctors and the public.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Health

Full bill text is not yet cached locally.

Open text view Read on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.

HR3491DeOndra Dixon INCLUDE Project Act of 2025
Reported by Committee · 2026-05-21
HRES1285Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
Referred to Committee · 2026-05-14
HR8432To provide the Food and Drug Administration needed authorities to carry out its regulatory mission with respect to human foods, to provide additional resources and authorities with respect to human foods research, and for other purposes.
Referred to Committee · 2026-04-22
HR7425Colorado Wilderness Act of 2026
Referred to Committee · 2026-02-09

Follow the Science Act